Anavex Life Sciences Corp. (AVXL)
1.225
+0.08
(+6.52%)
USD |
NASDAQ |
Nov 09, 16:00
1.225
0.00 (0.00%)
After-Hours: 18:30
Anavex Life Sciences Gross Profit (Annual) : 0.00 for Sept. 30, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | 0.00 |
| September 30, 2024 | 0.00 |
| September 30, 2023 | 0.00 |
| September 30, 2022 | 0.00 |
| September 30, 2021 | 0.00 |
| September 30, 2020 | 0.00 |
| September 30, 2019 | 0.00 |
| September 30, 2018 | 0.00 |
| September 30, 2017 | 0.00 |
| September 30, 2016 | -0.0013M |
| September 30, 2015 | -0.001M |
| Date | Value |
|---|---|
| September 30, 2014 | -0.0008M |
| September 30, 2013 | -0.0006M |
| September 30, 2012 | -0.0019M |
| September 30, 2011 | -0.0017M |
| September 30, 2010 | 0.00 |
| September 30, 2009 | -0.0004M |
| September 30, 2008 | -0.0002M |
| September 30, 2007 | 0.00 |
| September 30, 2006 | 0.00 |
| September 30, 2005 | 0.00 |
| September 30, 2004 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Vaxcyte, Inc. | -24.86M |
| Foghorn Therapeutics, Inc. | 27.58M |
| Connect Biopharma Holdings Ltd. | 0.00 |
| Caribou Biosciences, Inc. | 7.514M |
| Arrowhead Pharmaceuticals, Inc. | 805.52M |